Showing results (111-120 of 179) with videos related to
Sort By:
Pageof 18
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|August 26, 2006
A three-compartment thermometry model for the improved estimation of changes in body heat contentOllie Jay, Louise M Gariépy, Francis D Reardon, et al.HIV Medicine|September 30, 2023
Rate of response to initial antiretroviral therapy according to level of pre-existing HIV-1 drug resistance detected by next-generation sequencing in the strategic timing of antiretroviral treatment (START) studyAlessandro Cozzi-Lepri, David Dunn, Anna Tostevin, et al.BMC Medical Genomics|February 24, 2011
Integrative analysis of next generation sequencing for small non-coding RNAs and transcriptional regulation in Myelodysplastic SyndromesDominik Beck, Steve Ayers, Jianguo Wen, et al.Journal of Cell Science|March 1, 2002
Generation of diacylglycerol molecular species through the cell cycle: a role for 1-stearoyl, 2-arachidonyl glycerol in the activation of nuclear protein kinase C-betaII at G2/MElizabeth M Deacon, Trevor R Pettitt, Paul Webb, et al.Breast Cancer Research : BCR|July 5, 2017
Somatic loss of estrogen receptor beta and p53 synergize to induce breast tumorigenesisIgor Bado, Fotis Nikolos, Gayani Rajapaksa, et al.Nanomedicine : Nanotechnology, Biology, and Medicine|February 14, 2019
HBO1 directs histone H4 specific acetylation, potentiating mechano-transduction pathways and membrane elasticity in ovarian cancer cellsMarcos Quintela, Douglas H Sieglaff, Andrea Salvatore Gazze, et al.Aviation, Space, and Environmental Medicine|November 16, 2002
Skin microvascular flow during hypobaric exposure with and without a mechanical counter-pressure space suit gloveKunihiko Tanaka, James Waldie, Gregory C Steinbach, et al.AIDS (London, England)|May 11, 2002
Both baseline HIV-1 drug resistance and antiretroviral drug levels are associated with short-term virologic responses to salvage therapyJohn D Baxter, Thomas C Merigan, Deborah N Wentworth, et al.HIV Clinical Trials|November 29, 2007
The Incidence of HIV drug resistance and its impact on progression of HIV disease among antiretroviral-naïve participants started on three different antiretroviral therapy strategiesMichael J Kozal, Katherine Huppler Hullsiek, Rodger D Macarthur, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|September 5, 2006
Disadvantages of structured treatment interruption persist in patients with multidrug-resistant HIV-1: final results of the CPCRA 064 studyJody Lawrence, Katherine Huppler Hullsiek, Lisa M Thackeray, et al.Pageof 18